Pharmaceutical Industry Requests Price Increase Amid Cancer Drug Shortage
Industry seeks one-time price hike as cancer drug shortage worsens
Business Standard
Image: Business Standard
Pharmaceutical companies are requesting a one-time price increase for cancer drugs cisplatin and carboplatin due to rising platinum costs and raw material shortages, which are impacting hospital supplies nationwide.
- 01Pharmaceutical companies are facing shortages of cisplatin and carboplatin.
- 02The industry is calling for a one-time price hike for these drugs.
- 03Rising platinum costs are a significant factor in the supply disruptions.
- 04Raw material constraints are further complicating the situation.
- 05Hospitals across the country are experiencing supply issues for these essential cancer treatments.
Advertisement
In-Article Ad
The pharmaceutical industry is advocating for a one-time price increase for the cancer drugs cisplatin and carboplatin, as ongoing shortages are severely impacting hospital supplies across the country. The request comes in response to escalating platinum costs and constraints on raw materials, which have disrupted the production of these critical medications. The shortage is increasingly concerning for healthcare providers, as they struggle to meet the needs of cancer patients requiring these essential treatments.
Advertisement
In-Article Ad
The shortage of cisplatin and carboplatin may lead to treatment delays for cancer patients in hospitals.
Advertisement
In-Article Ad
Reader Poll
Do you support a one-time price increase for cancer drugs to address shortages?
Connecting to poll...
Read the original article
Visit the source for the complete story.